RT Journal
T1 OMission of financial disclosure information
JF JAMA
JO JAMA
YR 1999
FD April 7
VO 281
IS 13
SP 1174
OP 1174
DO 10.1001/jama.281.13.1174
UL http://dx.doi.org/10.1001/jama.281.13.1174
AB 
In the Original Contribution entitled "Weight Control and Risk Factor Reduction in
Obese Subjects Treated for 2 Years With Orlistat: A Randomized
Controlled Trial" published in the January 20, 1999, issue of
THE JOURNAL (1999;281:235-242), there was
incorrect or missing information in the "Methods" section, in the
legend for Figure 2, in
Table 3, and in the legend for Figure 3.
On page 236, under the heading "Assessments," "triglycerides higher
than 2.54 mmol/L (98.2 mg/dL), untreated" should have read 225 mg/dL.
On page 239, in Figure 2
, the legend for the empty box of "Orlistat,
60 and 120 mg" should have been 120, then 60 mg. In
Table 3, the
placebo measurement for low-density lipoprotein cholesterol, week 104,
of 25±4 mg/dL should have been 125±4
mg/dL. On page 240, in Figure 3
, under the letter C in the
figure legend, "P<.05 for placebo vs orlistat" should be
added.